| Emily J Chop, OTD, OTR/L | |
|
1820 Hillcrest Dr, Bellevue, NE 68005-3636 | |
| (402) 682-4808 | |
| Not Available |
| Full Name | Emily J Chop |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1820 Hillcrest Dr, Bellevue, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316592462 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2348 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily J Chop, OTD, OTR/L 2515 N 109th Ct # 4-304, Omaha, NE 68164-3872 Ph: (970) 290-8374 | Emily J Chop, OTD, OTR/L 1820 Hillcrest Dr, Bellevue, NE 68005-3636 Ph: (402) 682-4808 |
News Archive
Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman's risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association's Scientific Sessions 2014 in Chicago, IL.
Out of the 536 women who were killed between 1992-2016 in Denmark, 300 were killed by their partner. This figure corresponds to 57 per cent of all homicides with female victims.
According to a multinational clinical trial involving nearly 20,000 young women, the human papilloma virus vaccine, Cervarix, not only has the potential to prevent cervical cancer, but was effective against other common cancer-causing human papillomaviruses, aside from just the two HPV types, 16 and 18, which are responsible for about 70 percent of all cases.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers.
› Verified 6 days ago
Michaella Marie Gorman, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2600 Arboretum Dr, Bellevue, NE 68005 Phone: 402-293-4032 | |
Kristin Jo Heesacker, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-555-5555 | |
Mr. Dennis D Bickley, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2102 Harvell Circle, Bellevue, NE 68005 Phone: 402-293-5500 Fax: 402-293-5505 | |
Rebecca Lynn Bagwell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-682-4263 | |
Kaitlyn O'leary, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-291-8500 | |
Devin Urzendowski, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-682-4263 | |
Tina Ripple, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-291-8500 |